Alnylam Pharmaceuticals Inc.

NASDAQ: ALNY
Share price (3/25/25): $280.96
Market cap (3/25/25): $36.4 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Automatic shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

Pyott David E I

Pyott David E I

News Filter

Announces FDA Approval of AMVUTTRA® (Vutrisiran), the First RNAi Therapeutic to Reduce Cardiovascular Death, Hospitalizations and Urgent Heart Failure Visits in Adults With ATTR Amyloidosis With Cardiomyopathy

Announces Retirement of Longtime Board Member, Dr. Phillip A. Sharp, Company Co-Founder and Industry Luminary

Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Period Progress

Announces Preliminary* Fourth Quarter and Full Year 2024 Global Net Product Revenues and Provides 2025 Combined Net Product Revenue Guidance and Pipeline Goals

Reports Third Quarter 2024 Financial Results and Highlights Recent Period Activity

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission